Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ishitsuka

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1993
Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridineH Eda, K Fujimoto, S Watanabe, et al.
Japanese Journal of Cancer Research : Gann|March 1, 1993
Cytokines induce uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5'-deoxy-5-fluorouridineH Eda, K Fujimoto, S Watanabe, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1991
[Comparative studies on the antitumor activity of fluorinated pyrimidine derivatives against human bladder, cervical and ovarian cancer xenografts in nude mice]M Miwa, F Sekiguchi, H Akaza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
High susceptibility of human cancer xenografts with higher levels of cytidine deaminase to a 2'-deoxycytidine antimetabolite, 2'-deoxy-2'-methylidenecytidineM Miwa, H Eda, M Ura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1993
[Antitumor activity of various cytostatics in mice bearing murine advanced tumors]K Fujimoto-Ouchi, S Tamura, K Mori, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissueM Miwa, M Ura, M Nishida, et al.
Chemical & Pharmaceutical Bulletin|April 1, 1990
Comparative studies on the antitumor and immunosuppressive effects of the new fluorouracil derivative N4-trimethoxybenzoyl-5'-deoxy-5-fluorocytidine and its parent drug 5'-deoxy-5-fluorouridineM Miwa, T Ishikawa, H Eda, et al.
British Journal of Cancer|July 7, 2000
Effect of a fluorinated pyrimidine on cachexia and tumour growth in murine cachexia models: relationship with a proteolysis inducing factorH J Hussey, P T Todorov, W N Field, et al.
Japanese Journal of Cancer Research : Gann|February 1, 1990
Comparative antitumor activity and intestinal toxicity of 5'-deoxy-5-fluorouridine and its prodrug trimethoxybenzoyl-5'-deoxy-5-fluorocytidineY Ninomiya, M Miwa, H Eda, et al.
Cancer Research|April 15, 1990
Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in miceY Tanaka, H Eda, T Tanaka, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Cancer Chemotherapy and Pharmacology|January 1, 1993
Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridineH Eda, K Fujimoto, S Watanabe, et al.
Japanese Journal of Cancer Research : Gann|March 1, 1993
Cytokines induce uridine phosphorylase in mouse colon 26 carcinoma cells and make the cells more susceptible to 5'-deoxy-5-fluorouridineH Eda, K Fujimoto, S Watanabe, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1991
[Comparative studies on the antitumor activity of fluorinated pyrimidine derivatives against human bladder, cervical and ovarian cancer xenografts in nude mice]M Miwa, F Sekiguchi, H Akaza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
High susceptibility of human cancer xenografts with higher levels of cytidine deaminase to a 2'-deoxycytidine antimetabolite, 2'-deoxy-2'-methylidenecytidineM Miwa, H Eda, M Ura, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 1, 1993
[Antitumor activity of various cytostatics in mice bearing murine advanced tumors]K Fujimoto-Ouchi, S Tamura, K Mori, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissueM Miwa, M Ura, M Nishida, et al.
Chemical & Pharmaceutical Bulletin|April 1, 1990
Comparative studies on the antitumor and immunosuppressive effects of the new fluorouracil derivative N4-trimethoxybenzoyl-5'-deoxy-5-fluorocytidine and its parent drug 5'-deoxy-5-fluorouridineM Miwa, T Ishikawa, H Eda, et al.
British Journal of Cancer|July 7, 2000
Effect of a fluorinated pyrimidine on cachexia and tumour growth in murine cachexia models: relationship with a proteolysis inducing factorH J Hussey, P T Todorov, W N Field, et al.
Japanese Journal of Cancer Research : Gann|February 1, 1990
Comparative antitumor activity and intestinal toxicity of 5'-deoxy-5-fluorouridine and its prodrug trimethoxybenzoyl-5'-deoxy-5-fluorocytidineY Ninomiya, M Miwa, H Eda, et al.
Cancer Research|April 15, 1990
Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in miceY Tanaka, H Eda, T Tanaka, et al.
Pageof 7